Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept crossover study of Rupatadine in acquired cold urticaria
2007-005786-35Phase 3Completed
- Sponsor
- Uriach
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rupatadine in Cold urticaria (CU) (2 arms), sponsored by Uriach. Primary endpoints: critical stimulation time thresholds and critical temperature thresholds. Started Dec 2007; status: completed.
02
Drugs
rupatadine
03
Conditions
Cold urticaria (CU)
Beyond the preview
Go deeper on 2007-005786-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005786-35.